Erectile dysfunction — all decisions

The Board denied service connection for diabetes mellitus, erectile dysfunction, hypertension, heart disorder, and peripheral neuropathy of the upper and lower extremities as there was no evidence to support a link between these conditions and the Veteran's military service.

The Board remands the claims for service connection for PTSD and erectile dysfunction, to include as secondary to diabetes mellitus, type II, due to the Veteran's failure to appear for scheduled VA examinations without good cause.

The Board denied the Veteran's claim for service connection for erectile dysfunction, finding no evidence that it was related to his service or secondary to his service-connected PTSD.

The Board granted service connection for erectile dysfunction, a heart condition, and irritable bowel syndrome based on in-service exposure to toxins.

The Board granted an effective date of March 18, 2016, for the award of service connection for erectile dysfunction and special monthly compensation (SMC) based on loss of use of a creative organ.

The Board denied an effective date prior to May 16, 2023, for the award of service connection for erectile dysfunction and remanded claims for a compensable rating for erectile dysfunction and service connection for a nasal disability as secondary to GERD.

The Board denied service connection for chemical exposures, erectile dysfunction, and sleep disturbance disorder, to include insomnia.

The Board granted service connection for bilateral pes planus and denied the claims for a urinary disability, an earlier effective date for erectile dysfunction, and compensable ratings for pseudofolliculitis barbae, right ankle scars, and other conditions. The cervical spine and GERD with gastritis claims were remanded.

The Board remands the claim for service connection for cause of death due to a need for additional evidence and an adequate medical examination.

The Board denied increased ratings for the veteran's service-connected conditions and granted SMC at the statutory housebound rate from July 5, 2023. The decision also remanded several claims related to secondary service connection.

The Veteran is granted special monthly compensation (SMC) based on a need for aid and attendance due to service-connected disabilities, which includes PTSD, diabetes, hearing loss, and other conditions.

The Board granted service connection for bilateral hearing loss and tinnitus, but denied service connection for vertigo, depression, anxiety, headaches, a neck disability, dermatitis, erectile dysfunction, hypertension, sleep apnea, chronic fatigue, and a back disability.

The Board denied the Veteran's claim for a compensable rating for erectile dysfunction and low sperm count, as the Rating Schedule does not provide for a compensable rating under Diagnostic Code 7522.

The Board denied the Veteran's claim for an initial compensable rating for erectile dysfunction, as the highest schedular rating has already been assigned and SMC is in effect.

The veteran's appeal requests for extensions to file an appeal on various rating decisions were denied, and the attempted appeals are dismissed.

The Board denied service connection for headaches and denied initial compensable disability ratings for erectile dysfunction, orchitis, unilateral, chronic, anxiety disorder, unspecified, fracture, 5th metacarpal bone, right hand, and lumbosacral strain.

The Veteran's appeal for service connection for various conditions was dismissed due to a late filing of the Board Appeal request.

The Board dismissed the appeals for service connection of chronic fatigue, hypertension, cardiovascular ailments, fibromyalgia, erectile dysfunction, OSA, migraines, lower back pain, and Gulf War Syndrome due to untimely filings or lack of clarification.

The Board remands the issues of entitlement to service connection for a heart condition and erectile dysfunction due to or aggravated by service-connected disabilities for further development, including obtaining adequate medical opinions.

The Board remands the claims for further development and evidence collection, as some relevant private treatment records have not been obtained.